Heart Failure, Congestive Clinical Trial
Official title:
Utilizing Technology for Optimization of Pain Management and Mobilization in High Risk Cardiac Surgical ICU Patients
The purpose of this project is to improve mobility in the perioperative period using activity
trackers to augment current practice.
Delirium and poor functional status following ICU stays are intractable problems for which
clear solutions do not exist. Digital health approaches have not been applied to these
problems in the ICU setting and may represent a viable and unexplored intervention.
The program will involve the utilization of an activity tracker in ambulating patients. There
will be two arms to the program. The first will involve the longitudinal study of ambulating
lung transplant patients. Patients will be given an activity tracker at time of transplant
which will continue throughout their care into their first month at home. The data will be
collected to identify correlation between activity and clinical outcomes.
Early mobilization of patients, minimizing sedatives, maximizing pain control, optimizing
sleep are strongly associated with decreased rates of delirium, decreased ICU length of stay,
decreased hospital length of stay as well as improved functional status and quality of life
at 1 year. Cardiac surgical patients that are at high risk of prolonged stay in the ICU due
to the inherent nature of their disease (ie need for MCS (mechanical circulatory support) or
lung transplantation) are most likely to benefit from a systematic aggressive approach to
early mobilization. Technology such as activity trackers and virtual reality have been
studied in general surgical populations but with limited data in the ICU and to date no
studies in a cardiac surgical population. Activity trackers utilized in a multidisciplinary
team to provide objective data to care teams and patients can be used to develop goal setting
and patient motivation for teams, thereby improving mobility
Overall Goal: To evaluate whether quantitative information on post procedural ambulation in
mechanical device patients, cardiac surgical patients and lung transplant patients can
improve care teams ability to monitor and identify patients at high risk for complications
and prolonged length of stay.
- The purpose of the research is to improve mobility in the perioperative period using
Activity Trackers to augment current practice.
- Objective quantification and improvement in activity of post cardiac surgery patients
might result in improved clinical outcomes, thereby making this tool a part of routine
practice.
Patient Populations:
1. Lung transplant patients
2. Routine postoperative Cardiac surgical patients (elective cardiac surgical procedures
including CABG and Valve replacement)
3. Device Patients (axillary patients pre-open heart transplantation (OHT). Post MCS
patients)
Specific Aim 1: Create standardized trajectories for ambulation of study subject populations
from time of index procedure to 30 days postoperatively Specific Aim 2: To determine if
deviation from the standardized trajectory of postoperative ambulation predicts disposition
(home, rehabilitation facility or SNF), length of stay, 30 day readmissions, intensive care
unit (ICU) readmission, DVT, respiratory insufficiency (aspiration) Specific Aim 3: To
determine if decline in ambulation over 48 hours for a given patient predicts outcomes
including length of stay, readmission to an icu, readmission to hospital, deep vein
thrombosis (DVT), respiratory insufficiency.
The purpose of this project is to improve mobility in the perioperative period using activity
trackers to augment current practice.
Delirium and poor functional status following ICU stays are intractable problems for which
clear solutions do not exist. Digital health approaches have not been applied to these
problems in the ICU setting and may represent a viable and unexplored intervention.
The program will involve the utilization of an activity tracker in ambulating patients. There
will be two arms to the program. The first will involve the longitudinal study of ambulating
lung transplant patients. Patients will be given an activity tracker at time of transplant
which will continue throughout their care into their first month at home. The data will be
collected to identify correlation between activity and clinical outcomes.
The second part of the program will be within the intensive care unit. The daily step count
will be recorded for all ambulatory patients that fall into one of the defined subject
populations and have signed informed consent. Step counts will be displayed for the care
teams as well as the patient. This will be utilized by team to continuously evaluate and
modify physical mobility goals for the patient with earlier recognition of decreasing
mobility which is associated with worse outcomes. The goals and progress for the patient will
be displayed to the nursing staff and the patient which we hypothesize will increase
motivation.
Our hypothesis is that these interventions will increase mobility, decrease ICU length of
stay, optimize the ICU experience, and potentially increase in 6-month functional status.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01357850 -
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
|
Phase 2 | |
Recruiting |
NCT00532688 -
N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
|
Phase 2/Phase 3 | |
Terminated |
NCT00383630 -
Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure
|
Phase 2 | |
Completed |
NCT00531661 -
CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients
|
N/A | |
Completed |
NCT00149435 -
Cardiovascular Health Study (CHS) Events Follow-up Study
|
||
Terminated |
NCT00125437 -
Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy
|
N/A | |
Completed |
NCT00159614 -
Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment
|
Phase 2 | |
Completed |
NCT00241761 -
Epidemiology of Depression and Heart Failure in Aging
|
N/A | |
Terminated |
NCT00357591 -
Randomized Trial for Patients With Chronic Heart Failure With Acute Decompensation
|
N/A | |
Completed |
NCT00202579 -
Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure
|
Phase 2 | |
Completed |
NCT00094263 -
Long-Term Predictors of Morbidity in Older Age
|
N/A | |
Completed |
NCT00048425 -
Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
|
Phase 3 | |
Completed |
NCT00023556 -
Genetic Architecture of Heart Disease in Rural Brazil
|
N/A | |
Completed |
NCT00530426 -
Heart Failure Registry
|
Phase 4 | |
Terminated |
NCT00190359 -
Growth Hormone and Heart Failure
|
N/A | |
Completed |
NCT00004562 -
Occluded Artery Trial (OAT)
|
Phase 3 | |
Completed |
NCT00005265 -
Natural History of Coronary Heart Disease
|
N/A | |
Completed |
NCT02772068 -
Hemodynamic Response to Exercise in HFpEF Patients After Upregulation of SERCA2a
|
Early Phase 1 | |
Completed |
NCT02925546 -
A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets
|
Phase 1 | |
Completed |
NCT01074307 -
A Prospective, Open-labeled, Multi-centric Trial in Subjects With Systolic Heart Failure to Evaluate Bisoprolol Treatment for the Effects on Surrogate Markers of Heart Failure in Korea
|
Phase 4 |